Tapani Viitala

Dr. Tapani Viitala

University of Helsinki, Faculty of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Journal of Controlled Release
Verified
Journal Article
Open access
HSHeikki Saari
Heikki Saari
ELElisa Lázaro-Ibáñez
Elisa Lázaro-Ibáñez
Tapani ViitalaTapani Viitala
Tapani Viitala
EVElina Vuorimaa-Laukkanen
Elina Vuorimaa-Laukkanen
PSPia Siljander
Pia Siljander
MYMarjo Yliperttula
Marjo Yliperttula
Extracellular vesicles (EVs) are naturally occurring membrane particles that mediate intercellular communication by delivering molecular information between cells. In this study, we investigated the effectiveness of two different populations of EVs (microvesicle- and exosome-enriched) as carriers of Paclitaxel to autologous prostate cancer cells. EVs were isolated from LNCaP- and PC-3 prostate cancer cell cultures using differential centrifugation and characterized by electron microscopy, nanoparticle tracking analysis, and Western blot. The uptake of microvesicles and exosomes by the autologous prostate cancer cells was assessed by flow cytometry and confocal microscopy. The EVs were loaded with Paclitaxel and the effectiveness of EV-mediated drug delivery was assessed with viability assays. The distribution of EVs and EV-delivered Paclitaxel in cells was inspected by confocal microscopy. Our main finding was that the loading of Paclitaxel to autologous prostate cancer cell-derived EVs increased its cytotoxic effect. This capacity was independent of the EV population and the cell line tested. Although the EVs without the drug increased cancer cell viability, the net effect of enhanced cytotoxicity remained. Both EV populations delivered Paclitaxel to the recipient cells through endocytosis, leading to the release of the drug from within the cells. The removal of EV surface proteins did not affect exosomes, while the drug delivery mediated by microvesicles was partially inhibited. Cancer cell-derived EVs can be used as effective carriers of Paclitaxel to their parental cells, bringing the drug into the cells through an endocytic pathway and increasing its cytotoxicity. However, due to the increased cell viability, the use of cancer cell-derived EVs must be further investigated before any clinical applications can be designed.

1 January 2015 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
ZSZachary Smith
Zachary Smith
CLChangwon Lee
Changwon Lee
TRTatu Rojalin
Tatu Rojalin
RCRandy P. Carney
Randy P. Carney
SHSidhartha Hazari
Sidhartha Hazari
SWSebastian Wachsmann‐Hogiu
Sebastian Wachsmann‐Hogiu
Current analysis of exosomes focuses primarily on bulk analysis, where exosome‐to‐exosome variability cannot be assessed. In this study, we used Raman spectroscopy to study the chemical composition of single exosomes. We measured spectra of individual exosomes from 8 cell lines. Cell‐line‐averaged spectra varied considerably, reflecting the variation in total exosomal protein, lipid, genetic, and cytosolic content. Unexpectedly, single exosomes isolated from the same cell type also exhibited high spectral variability. Subsequent spectral analysis revealed clustering of single exosomes into 4 distinct groups that were not cell‐line specific. Each group contained exosomes from multiple cell lines, and most cell lines had exosomes in multiple groups. The differences between these groups are related to chemical differences primarily due to differing membrane composition. Through a principal components analysis, we identified that the major sources of spectral variation among the exosomes were in cholesterol content, relative expression of phospholipids to cholesterol, and surface protein expression. For example, exosomes derived from cancerous versus non‐cancerous cell lines can be largely separated based on their relative expression of cholesterol and phospholipids. We are the first to indicate that exosome subpopulations are shared among cell types, suggesting distributed exosome functionality. The origins of these differences are likely related to the specific role of extracellular vesicle subpopulations in both normal cell function and carcinogenesis, and they may provide diagnostic potential at the single exosome level.

21 May 2014 in Scientific Reports
Verified
Journal Article
Open access
AMAniket Magarkar
Aniket Magarkar
VDVivek Dhawan
Vivek Dhawan
PKParaskevi Kallinteri
Paraskevi Kallinteri
Tapani ViitalaTapani Viitala
Tapani Viitala
MEMohammed Elmowafy
Mohammed Elmowafy
ABAlex Bunker
Alex Bunker
Cholesterol is an important component of all biological membranes as well as drug delivery liposomes. We show here that increasing the level of cholesterol in a phospholipid membrane decreases surface charge in the physiological environment. Through molecular dynamics simulation we have shown that increasing the level of cholesterol decreases Na+ ion binding. Complementary experimental ζ – potential measurements have shown a decreased ζ – potential with increasing cholesterol content, indicative of reduced surface charge. Both experiments and simulations have been carried out on both saturated 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and monounsaturated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membranes. This result is particularly important because membrane surface charge plays an important role in the interactions of biomembranes with peripheral membrane proteins and drug delivery liposomes with the immune system.

1 August 2011 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
NSNiklas Sandler
Niklas Sandler
AMAnni Määttänen
Anni Määttänen
PIPetri Ihalainen
Petri Ihalainen
LKLeif Kronberg
Leif Kronberg
AMAxel Meierjohann
Axel Meierjohann
JPJouko Peltonen
Jouko Peltonen

1 October 2016 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
ABAlex Bunker
Alex Bunker
AMAniket Magarkar
Aniket Magarkar
Tapani ViitalaTapani Viitala
Tapani Viitala

19 February 2005 in Macromolecules
Verified
Journal Article
Closed access
JSJun Shan
Jun Shan
MNMarkus Nuopponen
Markus Nuopponen
HJHua Jiang
Hua Jiang
Tapani ViitalaTapani Viitala
Tapani Viitala
EKEsko I. Kauppinen
Esko I. Kauppinen
HTHeikki Tenhu
Heikki Tenhu